title: Periventricular leukomalacia long-term prognosis may be improved by treatment with UDP-glucose, GDNF, and memantine in neonatal rats.
abstract: The therapeutic effects of UDP-glucose (UDPG), an endogenous agonist of GPR17 that may promote the self-repair of white matter, glial cell line-derived neurotrophic factor (GDNF), a neurotrophic factor correlated with the growth and survival of nerve cells, and memantine, an antagonist of NMDA receptors, were evaluated for functional improvement of neonatal rats with experimental periventricular leukomalacia (PVL). Five day-old neonatal rat pups were subjected to an ischemia-induced model of PVL. The pups were then randomly divided into sham, PVL, PVL plus UDPG, PVL plus GDNF, and PVL plus memantine groups. All pups were weighed and the age at first eye opening recorded. Pathological changes and myelin sheath formation in the white matter were assessed under both light and electron microscopy on day 7 and 21 after induction of PVL. Values of escape latency (EL) and swimming distance (SD) in Morris water maze test, and the modified inclined plane scores in Rivlin inclined plane test were recorded for rats on day 26. Pups in the PVL group were found to be significantly lower in weight (p<0.05), delayed in age at first eye opening (p<0.01), and impaired in their inclined plane (p<0.01) and Morris water maze (p<0.01) performance compared with those in the sham, UDPG, GDNF and memantine groups. Histopathological grading of the white matter classified all pups in the PVL group with significantly more severe injury (p<0.01), and the number and thickness of their myelin sheaths were significantly less (p<0.01), compared to the UDPG, GDNF, memantine, or sham groups. These results indicate that treatment with UDPG, GDNF, and memantine may significantly improve long-term prognosis in neonatal rats with cerebral white matter injury, characteristic of PVL.
authors.affiliation: Shanghai Institute for Pediatric Research, Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Kongjiang Road 1665, Shanghai 200092, PR China.
authors.forename: Feng-Xia
authors.initials: FX
authors.lastname: Mao
authors.forename: Wen-Juan
authors.initials: WJ
authors.lastname: Li
authors.forename: Hui-Jin
authors.initials: HJ
authors.lastname: Chen
authors.forename: Long-Hua
authors.initials: LH
authors.lastname: Qian
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Buzby
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D002552:Cerebral Ventricles / Q000187:drug effects / Q000473:pathology; D002561:Cerebrovascular Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D004359:Drug Therapy, Combination; D051100:Glial Cell Line-Derived Neurotrophic Factor / Q000008:administration & dosage*; D018782:Maze Learning / Q000187:drug effects / Q000502:physiology; D008559:Memantine / Q000008:administration & dosage*; D009413:Nerve Fibers, Myelinated / Q000187:drug effects / Q000473:pathology; D011379:Prognosis; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D013997:Time Factors; D016896:Treatment Outcome; D014532:Uridine Diphosphate Glucose / Q000008:administration & dosage*
chemical_list: D051100:Glial Cell Line-Derived Neurotrophic Factor; D014532:Uridine Diphosphate Glucose; D008559:Memantine